Possible Ameliorating Effect of N- Acetylcysteine (NAC) on Type-II Diabetes Induced Nephropathy

Clinical trial NCT04531163 · UNKNOWN

Trial details

NCT number: NCT04531163
Sponsor: Al-Azhar University
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Kidney Disease Diabetes Mellitus, Type 2 Diabetic Nephropathies

Start date: 2019-10-01
Primary completion: 2020-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.